Management of endometrial cancer

Issues and controversies

G. Bogani, Sean Christopher Dowdy, William Arthur Cliby, F. Ghezzi, D. Rossetti, L. Frigerio, A. Mariani

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Although endometrial cancer (EC) is the most common gynecologic cancer in developed countries, several aspects of its management are still controversial. In particular, the need to perform lymphadenectomy represents an important matter of discussion. Because of the discordant results in the literature, it is still not possible to draft any definitive conclusions regarding the therapeutic value of lymph node dissection. The present review discusses the role of lymphadenectomy in the setting of EC, risk factors for lymphatic spread, identification of patients at risk for lymph node dissemination, and the current evidence for adjuvant therapies in patients with positive nodes. Reasons for the difficulty in demonstrating any therapeutic value of pelvic and para-aortic lymphadenectomy are also discussed.

Original languageEnglish (US)
Pages (from-to)6-12
Number of pages7
JournalEuropean Journal of Gynaecological Oncology
Volume37
Issue number1
DOIs
StatePublished - 2016

Fingerprint

Endometrial Neoplasms
Lymph Node Excision
Developed Countries
Therapeutics
Lymph Nodes
Neoplasms

Keywords

  • Adjuvant therapy
  • Endometrial cancer
  • Lymphadenectomy
  • Staging
  • Survival

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Management of endometrial cancer : Issues and controversies. / Bogani, G.; Dowdy, Sean Christopher; Cliby, William Arthur; Ghezzi, F.; Rossetti, D.; Frigerio, L.; Mariani, A.

In: European Journal of Gynaecological Oncology, Vol. 37, No. 1, 2016, p. 6-12.

Research output: Contribution to journalArticle

Bogani, G. ; Dowdy, Sean Christopher ; Cliby, William Arthur ; Ghezzi, F. ; Rossetti, D. ; Frigerio, L. ; Mariani, A. / Management of endometrial cancer : Issues and controversies. In: European Journal of Gynaecological Oncology. 2016 ; Vol. 37, No. 1. pp. 6-12.
@article{53528cde679a494abc98b6feeeabff35,
title = "Management of endometrial cancer: Issues and controversies",
abstract = "Although endometrial cancer (EC) is the most common gynecologic cancer in developed countries, several aspects of its management are still controversial. In particular, the need to perform lymphadenectomy represents an important matter of discussion. Because of the discordant results in the literature, it is still not possible to draft any definitive conclusions regarding the therapeutic value of lymph node dissection. The present review discusses the role of lymphadenectomy in the setting of EC, risk factors for lymphatic spread, identification of patients at risk for lymph node dissemination, and the current evidence for adjuvant therapies in patients with positive nodes. Reasons for the difficulty in demonstrating any therapeutic value of pelvic and para-aortic lymphadenectomy are also discussed.",
keywords = "Adjuvant therapy, Endometrial cancer, Lymphadenectomy, Staging, Survival",
author = "G. Bogani and Dowdy, {Sean Christopher} and Cliby, {William Arthur} and F. Ghezzi and D. Rossetti and L. Frigerio and A. Mariani",
year = "2016",
doi = "10.12892/ejgo2788.2016",
language = "English (US)",
volume = "37",
pages = "6--12",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "1",

}

TY - JOUR

T1 - Management of endometrial cancer

T2 - Issues and controversies

AU - Bogani, G.

AU - Dowdy, Sean Christopher

AU - Cliby, William Arthur

AU - Ghezzi, F.

AU - Rossetti, D.

AU - Frigerio, L.

AU - Mariani, A.

PY - 2016

Y1 - 2016

N2 - Although endometrial cancer (EC) is the most common gynecologic cancer in developed countries, several aspects of its management are still controversial. In particular, the need to perform lymphadenectomy represents an important matter of discussion. Because of the discordant results in the literature, it is still not possible to draft any definitive conclusions regarding the therapeutic value of lymph node dissection. The present review discusses the role of lymphadenectomy in the setting of EC, risk factors for lymphatic spread, identification of patients at risk for lymph node dissemination, and the current evidence for adjuvant therapies in patients with positive nodes. Reasons for the difficulty in demonstrating any therapeutic value of pelvic and para-aortic lymphadenectomy are also discussed.

AB - Although endometrial cancer (EC) is the most common gynecologic cancer in developed countries, several aspects of its management are still controversial. In particular, the need to perform lymphadenectomy represents an important matter of discussion. Because of the discordant results in the literature, it is still not possible to draft any definitive conclusions regarding the therapeutic value of lymph node dissection. The present review discusses the role of lymphadenectomy in the setting of EC, risk factors for lymphatic spread, identification of patients at risk for lymph node dissemination, and the current evidence for adjuvant therapies in patients with positive nodes. Reasons for the difficulty in demonstrating any therapeutic value of pelvic and para-aortic lymphadenectomy are also discussed.

KW - Adjuvant therapy

KW - Endometrial cancer

KW - Lymphadenectomy

KW - Staging

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84960927272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960927272&partnerID=8YFLogxK

U2 - 10.12892/ejgo2788.2016

DO - 10.12892/ejgo2788.2016

M3 - Article

VL - 37

SP - 6

EP - 12

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 1

ER -